It is therefore reasonable to speculate that MeCP2 acetylation patterns regulated by SIRT1 activity may not only influence MeCP2 function in a cancer context, but could also do so in other contexts wherein the specific lysine residue targeted will play an important role in cell-type specific biology. Here, SIRT1 is linked to cancer.